Literature DB >> 25522665

Regulation of T cells by mTOR: the known knowns and the known unknowns.

Kristen N Pollizzi1, Jonathan D Powell2.   

Abstract

Mammalian/mechanistic target of rapamycin (mTOR) is emerging as an important integrator of environmental cues critical for the regulation of T cell activation, differentiation, and function. Recent studies leveraging pharmacologic inhibition or T cell specific genetic deletion of signaling components in the mTOR pathway have provided important insights into the mechanisms involved, and have been informative in defining targets downstream of mTOR that promote immune regulation. However, these studies have also presented confusing and, at times, contradictory findings, highlighting the complexities involved in examining the mTOR pathway in distinct contexts. Here, we review current understanding of the roles of mTOR in T cell biology, highlighting emerging concepts and areas of investigation where the precise role of mTOR has yet to be fully discerned.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  T cells; mTOR; rapamycin

Mesh:

Substances:

Year:  2014        PMID: 25522665      PMCID: PMC4290883          DOI: 10.1016/j.it.2014.11.005

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  72 in total

1.  Ex vivo rapamycin generates apoptosis-resistant donor Th2 cells that persist in vivo and prevent hemopoietic stem cell graft rejection.

Authors:  Jacopo Mariotti; Jason Foley; Unsu Jung; Todd Borenstein; Nermina Kantardzic; Soo Han; Joshua T Hanson; Elaine Wong; Nicole Buxhoeveden; Jane B Trepel; Antonio Tito Fojo; William Telford; Daniel H Fowler
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

2.  A critical role for Rictor in T lymphopoiesis.

Authors:  Fei Tang; Qi Wu; Tsuneo Ikenoue; Kun-Liang Guan; Yang Liu; Pan Zheng
Journal:  J Immunol       Date:  2012-07-18       Impact factor: 5.422

Review 3.  Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.

Authors:  David J Kwiatkowski; Brendan D Manning
Journal:  Hum Mol Genet       Date:  2005-10-15       Impact factor: 6.150

4.  Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells.

Authors:  Heather Kopf; Gonzalo M de la Rosa; O M Zack Howard; Xin Chen
Journal:  Int Immunopharmacol       Date:  2007-09-20       Impact factor: 4.932

Review 5.  Metabolic control of regulatory T cell development and function.

Authors:  Hu Zeng; Hongbo Chi
Journal:  Trends Immunol       Date:  2014-09-20       Impact factor: 16.687

6.  Characterization of the metabolic phenotype of rapamycin-treated CD8+ T cells with augmented ability to generate long-lasting memory cells.

Authors:  Shan He; Koji Kato; Jiu Jiang; Daniel R Wahl; Shin Mineishi; Erin M Fisher; Donna M Murasko; Gary D Glick; Yi Zhang
Journal:  PLoS One       Date:  2011-05-17       Impact factor: 3.240

7.  Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism.

Authors:  Andrew N Macintyre; David Finlay; Gavin Preston; Linda V Sinclair; Caryll M Waugh; Peter Tamas; Carmen Feijoo; Klaus Okkenhaug; Doreen A Cantrell
Journal:  Immunity       Date:  2011-02-03       Impact factor: 31.745

8.  Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection.

Authors:  Shivani Srivastava; Meghan A Koch; Marion Pepper; Daniel J Campbell
Journal:  J Exp Med       Date:  2014-04-07       Impact factor: 14.307

9.  PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.

Authors:  David K Finlay; Ella Rosenzweig; Linda V Sinclair; Carmen Feijoo-Carnero; Jens L Hukelmann; Julia Rolf; Andrey A Panteleyev; Klaus Okkenhaug; Doreen A Cantrell
Journal:  J Exp Med       Date:  2012-11-26       Impact factor: 14.307

10.  The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex.

Authors:  Emily B Heikamp; Chirag H Patel; Sam Collins; Adam Waickman; Min-Hee Oh; Im-Hong Sun; Peter Illei; Archna Sharma; Aniko Naray-Fejes-Toth; Geza Fejes-Toth; Jyoti Misra-Sen; Maureen R Horton; Jonathan D Powell
Journal:  Nat Immunol       Date:  2014-04-06       Impact factor: 25.606

View more
  84 in total

Review 1.  Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional Cure.

Authors:  Stella J Berendam; Ashley N Nelson; Ria Goswami; Deborah Persaud; Nancy L Haigwood; Ann Chahroudi; Genevieve G Fouda; Sallie R Permar
Journal:  Curr HIV/AIDS Rep       Date:  2020-06       Impact factor: 5.071

2.  Resveratrol attenuates stimulated T-cell activation and proliferation: potential therapy against cellular rejection in organ transplantation.

Authors:  Jimmy Jh Kang; Sabin J Bozso; Dana E Boe; David P Al-Adra; Michael C Moon; Darren H Freed; Jayan Nagendran; Jeevan Nagendran
Journal:  Am J Clin Exp Immunol       Date:  2020-12-15

3.  mTOR Complex 1 Signaling Regulates the Generation and Function of Central and Effector Foxp3+ Regulatory T Cells.

Authors:  Im-Hong Sun; Min-Hee Oh; Liang Zhao; Chirag H Patel; Matthew L Arwood; Wei Xu; Ada J Tam; Richard L Blosser; Jiayu Wen; Jonathan D Powell
Journal:  J Immunol       Date:  2018-06-08       Impact factor: 5.422

4.  Self-Regulation of Memory CD8 T Cell Metabolism through Extracellular ATP Signaling.

Authors:  Kelsey M Wanhainen; Stephen C Jameson; Henrique Borges da Silva
Journal:  Immunometabolism       Date:  2019-07-23

Review 5.  T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production.

Authors:  Jinfang Zhu
Journal:  Cytokine       Date:  2015-06-01       Impact factor: 3.861

Review 6.  mTOR and other effector kinase signals that impact T cell function and activity.

Authors:  Darienne R Myers; Benjamin Wheeler; Jeroen P Roose
Journal:  Immunol Rev       Date:  2019-09       Impact factor: 12.988

7.  Proliferating Helper T Cells Require Rictor/mTORC2 Complex to Integrate Signals from Limiting Environmental Amino Acids.

Authors:  Lee-Ann Van de Velde; Peter J Murray
Journal:  J Biol Chem       Date:  2016-10-31       Impact factor: 5.157

Review 8.  MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells.

Authors:  Russell G Jones; Edward J Pearce
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

9.  Emerging role of mTOR in the response to cancer therapeutics.

Authors:  Erika Ilagan; Brendan D Manning
Journal:  Trends Cancer       Date:  2016-05

Review 10.  Artemisinin and its derivatives: a potential therapeutic approach for oral lichen planus.

Authors:  Rui-Jie Ma; Ming-Jing He; Ya-Qin Tan; Gang Zhou
Journal:  Inflamm Res       Date:  2019-02-01       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.